Lisocabtagene Maraleucel (Liso-Cel) in Patients (pt) with R/R MCL: Subgroup Analyses in Pts with High-Risk Disease Features from the MCL Cohort of the TRANSCEND NHL 001
BLOOD(2023)
关键词
Treatment Discontinuation
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要